Dr. Abdulrazak Abyad, Director, Abyad Medical Center and Middle-East Longevity Institute, Lebanon
Dr. Ajay K. Banga, Professor and Chair, Mercer University, USA
Dr. Alan C Rigby, Director, Harvard Medical School, USA
Dr. Alex Kiselyov, President, deCODE Chemistry, USA
Dr. Alex Odermatt, Professor, University of Basel, Switzerland
Dr. Amir Pelleg, President and CSO, Cordex Pharma, Inc., USA
Dr. Amos PANET, Professor, THE HEBREW UNIVERSITY OF JERUSALEM, Israel
Dr. Andrei Thomas-Tikhonenko, Chair, Cancer Biology Graduate Program, University of Pennsylvania, USA
Dr. Andrew C. Chang, Executive Director, PharmaNet Consulting, Pharmanet Development Group, Inc., USA
Dr. Aristidis Tsatsakis, President, University of Crete, Greece
Dr. Asad Ullah Khan, Associate Professor, Interdisciplinary Biotechnology Unit, Aligarh M University, India
Dr. Athina Geronikaki, Professor, Aristotelian University of Thessaloniki, Greece
Dr. Avram Hershko, Professor of Biochemistry, Technion - Israel Institute of Technology Rappaport Institute, Israel
Dr. B. S. Kasinath, Professor, University of Texas Health Science Center, USA
Dr. Bal L. Lokeshwar, Co-Director, Division of Urology Research, University of Miami School of Medicine, USA
Dr. Bal Lokeshwar, Associate Professor and Director of Gastroenterology Research, University of Oklahoma Health Sciences Center, USA
Dr. Bjorn Mellgord, Director Scientific Affairs, AstraZeneca, USA
Dr. Bolin Geng, Principal Scientist, Infection Discovery, AstraZeneca R&D, USA
Dr. Brian A Hemmings, Senior Scientist, Friedrich Miescher Institute for Biomedical Research, Switzerland
Dr. Brian A Whittle, Managing Director, Kings College London, Department of Pharmacy, UK
Dr. Brian Bronk, Senior Director, Pfizer, USA
Dr. Brian Meltzer, Senior Director, Venture Program Management, Johnson & Johnson Corporate Development, USA
Dr. Bruce Morimoto, Vice President, Allon Therapeutics Inc., USA
Dr. Carmela Abraham, Professor, Boston University School of Medicine, USA
Dr. Catherine Huang, Project Scientist, Reseach and Development, SeraCare Life Sciences, USA
Dr. Chaohong Sun, Research Investigator, Protein NMR Research, Abbott Laboratories, USA
Dr. Charles A. Dinarello, Professor, University of Colorado Health Sciences Center, USA
Dr. Charles H. Reynolds, Research Fellow, Computer-Aided Drug Discovery, Johnson & Johnson Pharma R&D, USA
Dr. Charlie Johannes, Director, Chemistry Forma Therapeutics, Inc., Singapore
Dr. Chengbin Wu, Associate Research Fellow, Abbott, USA
Dr. Choung U. Kim, Vice President, Chemistry, Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA
Dr. Chris Senanayake, Vice President, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., USA
Dr. Christian K Schneider, Head, Division EU-Cooperation/Microbiology, Paul-Ehrlich-Institute, Germany
Dr. Christopher Bianca, Professor of Chemistry, Clinical Consultant, Keystone College Academia, USA
Dr. Christopher O'Donnell, Director, Global Research & Development, Pfizer, USA
Dr. Christopher Yochim, Associate Director, External Relations, Strategic Planning & Business Development, AstraZeneca, UK
Dr. Chuang Lu, Associate Director, DMPK, Drug Safety and Disposition Millennium, The Takeda Oncology Company, USA
Dr. Claudio D. Denoya, Research Fellow - Group Leader, Pfizer Global R&D, USA
Dr. Clovis O. Da Fonseca, Associate Professor of Neurosurgery, Universidade Federal Fluminense, Brazil
Dr. D Bonnet, Senior Group Leader, London Research Institute, Haematopoietic Stem Cell Laboratory, UK
Dr. Damas Molero Sanchez, General Manager, 3 P Biopharmaceuticals, USA
Dr. Damian Lismore, CFO, Biota Holdings Limited, USA
Dr. Danhua Chen, Senior Principal Scientist, Pfizer Inc., USA
Dr. Danping Li, Director of Formulation Development, Rib-X Pharmaceuticals, USA
Dr. Darren Hodgson, Advisor, Clinical Biomarker Group, AstraZeneca, UK
Dr. Darren Hodgson, Biomics Advisor, AstraZeneca, UK
Dr. Darwin J. Prockop, Director, TInstitute for Regenerative Medicine, Scott & White, USA
Dr. David A. Winkler, Professor, CSIRO Molecular and Health Technologies, Australia
Dr. David Craik, Professor, Institute for Molecular Bioscience, The University of Queensland, Australia
Dr. David Rhodes, Head of Discovery, Avexa Ltd, Australia
Dr. Desire Collen, CEO, ThromboGenics, USA
Dr. Dhanya Menon, Marketing Portfolio Manager, Ocimum Biosolutions, India
Dr. Domenico Mastrangelo, Senior Scientist, Department of Ophthalmology, University of Siena, Italy
Dr. Domenico Pratico, Associate Professor, Pharmacology Temple University, USA
Dr. Dora M. Schnur, Principal Scientist, Bristol-Myers Squibb Company, USA
Dr. Douglas Macdonald, Director, Drug Discovery CHDI Management / CHDI Foundation, California
Dr. Dusica Maysinger, Associate Professor, Department of Pharmacology and Therapeutics, McGill University, Canada
Dr. Duu-Gong Wu, Executive Director, Consulting Division, PharmaNet, Inc., USA
Dr. Ekambar Kandimalla, Vice President, Discovery, Idera Pharmaceuticals, USA
Dr. Elena Vigorito, Group Leader, The Babraham Institute, UK
Dr. Emanuel F. Petricoin,Co-Director, Ctr. for Applied Proteomics and Molecular Medicine, USA
Dr. Erik Hessen, President of the Norwegian Neuropsychological Association, Akershus University Hospital, Norway
Dr. Esam Z. Dajani, President, IDDC Corporation, USA
Dr. Fabio Garofolo, Vice-president, Algorithme Pharma Inc., Canada
Dr. Frank Bretz, Director, Novartis Pharma AG, USA
Dr. Frank Zhang, CEO, genscript, USA
Dr. Galila Agam, Associate Professor, Ben-Gurion University of the Negev, Israel
Dr. Gary Wormser, Professor, New York Medical College, USA
Dr. George Lin, Chief Medical Officer, Biological Mimetics, Inc., USA
Dr. George Schlich, in-house counsel, Schlich & Co, UK
Dr. Girish KOTWAL, Professor, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, USA
Dr. Giulio M. Pasinetti, Professor, Departments of Psychiatry and Geriatrics and Adult Development, USA
Dr. Gloria Cristalli, Professor, Dean of the Pharmacy Faculty of the University of Camerino, Italy
Dr. Graeme Robertson, Vice President of Therapeutic Research, Siena Biotech S.p.A. A company, USA
Dr. Gregory Stahl, Professor, Harvard Medical School, USA
Dr. Guru Sonpavde, Clinical Assistant professor, US Oncology Research, Inc., USA
Dr. Gus Rosania, Associate Professor, University of Michigan, USA
Dr. Hai Wei, Associate Professor, Shanghai Unviversity of Traditional Chinese Medicine, China
Dr. Haiching Ma, Chief Technology Officer, Reaction Biology Corporation, USA
Dr. Hemant Sarin, Research Fellow, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, USA
Dr. Hengjun Gao, Vice President, Shanghai Biochip Co., Ltd, China
Dr. Hengmiao Cheng, Associate Research Fellow, Pfizer La Jolla Labs, USA
Dr. Hequn Yin, principle scientist, Shanghai R&D Center, Novartis, China
Dr. Heribert Stoibe, Professor, Innsbruck Medical University, Austria
Dr. Herman Waldmann, Cofounder, Chairman, Scientific Advisory Board Tolerx, USA
Dr. Hitoshi Matsushime, Director, Astellas Pharmaceutical Inc., Japan
Dr. Hong Wan, Principal Scientist, AstraZeneca R&D Molndal, Sweden
Dr. Horst P. Schmitt, Professor, Institute of Pathology, Department of Neuropathology, University of Heidelberg, Germany
Dr. Hua Gao, Associate Research Follow, Computational Chemistry, Pfizer, USA
Dr. Huaiyu Mi, Senior Biologist, SRI International, USA
Dr. Huifen Faye Wang, Director, PDM Bioanalytical Research Biotherapeutics, Pfizer, USA
Dr. Ian A Cliffe, Director - Head Medicinal Chemistry, Drug Discovery Research, Ranbaxy Laboratories Limited, India
Dr. Ian Gourley, Senior Director, Wyeth Research, USA
Dr. Igor Sherman, CEO, Alpha Cancer Technologies Inc., USA
Dr. Iman El-Hariry, Group Director, Oncology MDC, Europe GlaxoSmithKline R&D, UK
Dr. Isaiah (Shy) Arkin, Professor, The Hebrew University, Israel
Dr. J. Fred Pritchard, Vice President, Drug Development, Development and Regulatory Services, MDS Pharma Services, USA
Dr. James C. Lee, Professor, University of Texas Medical, USA
Dr. Jane Papadaki-Markley, Sales and Marketing Director for North America, DxS Ltd, USA
Dr. Jan-oke Gustafsson, Professor & Chairman, Dept. of Biosciences & Nutrition, Karolinska Institutet, Sweden
Dr. Jared Rutter, Assistant Professor, University of Utah School of Medicine, USA
Dr. Jason (Gang) Jin, Co-Founder and Executive Vice President of Global Business (CRO) of Shanghai Biochip Co., Ltd, China
Dr. Jason K. Kim, Director, Pennsylvania State University College of Medicine, USA
Dr. Jason K. Kim, Professor of Molecular Medicine, University of Massachusetts Medical School, USA
Dr. Jeffrey S. Albert, Principal Scientist, CNS Discovery Research, AstraZeneca Pharmaceuticals, USA
Dr. Jian Kuang, Associate Professor, MD Anderson Cancer Center, The University of Texas, USA
Dr. Jianling Wang, Head, ADME Profiling Cambridge, Novartis Institutes for Biomedical Research, USA
Dr. Jin Li, Co-founder and the Chief Operating Officer, Shenogen Pharma Group, China
Dr. Jingping Mo, Senior Director, Pfizer, USA
Dr. Jingsong Wang, Director, Discovery Medicine & Clinical Pharmacology, Bristol-Myers Squibbs, USA
Dr. Jinhe Li, Research Investigator, Abbott, USA
Dr. Jinhua Zhang, Senior Scientist, Simulations Plus, Inc., USA
Dr. Johan Weigelt, Associate Director/Chief Scientist, Structural Genomics Consortium Karolinska Institutet, Sweden
Dr. Johannes Oldenburg, Professor, Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany
Dr. John A. Cidlowski, Principal Investigator, Molecular Endocrinology Group, NIH, USA
Dr. John D. Baxter, Professor, Diabetes Center and Department of Medicine, University of California-San Francisco, USA
Dr. John F. Thompson, Professor, Royal Prince Alfred Hospital, The University of Sydney, Australia
Dr. John R. Cashman, Director and Founder, Human BioMolecular Re-. search Institute, USA
Dr. Jorg Vollmer, Managing Director, Coley Pharmaceutical GmbH, Germany
Dr. Jos Jonkers, Group leader, Netherlands Cancer Institute, The Netherlands
Dr. José Duca, Senior Principal Scientist, 3D - Drug Design Department, Schering Plough Research Institute, USA
Dr. Joseph K.-K. Li, Professor, Department of Biology, Utah State University, USA
Dr. Josy Breuer, Senior Director, Bayer Schering Pharma AG, Germany
Dr. Jun Shi Senior, Director, Daiichi Sankyo Pharma Development, Japan
Dr. Jurgen Moll, Director, Cell Biology Dep, Nerviano Medical Sciences, Italy
Dr. Jurgen Wagner, Unit Head, Neuroscience, Novartis Institutes, Switzerland
Dr. Kailash Swarna, Executive Director, Research & Development, Amgen, Inc., USA
Dr. Kailash Swarna, Executive Director, Research & Development, Amgen, Inc, USA
Dr. Kamaleshwar Prasad Singh, Lead Scientist, Genomic & Proteomic Facility, Texas Southern University, USA
Dr. Karsten Kristiansen, Professor, University of Southern Denmark, Denmark
Dr. Kaushik Mitra, Senior Research Chemist, Department of Drug Metabolism, Merck Research, USA
Dr. Keith D. Kaufman, Executive Director Clinical Research – Metabolism, Merck and Co., Inc., USA
Dr. Keizo Koya, Senior Vice President, Drug Development, Synta Pharmaceuticals Corp, USA
Dr. King Lee, VP Regulatory/Clinical Affairs, Cornerstone Pharmaceuticals, USA
Dr. L. Van Gaal, Professor, Dept. Endocrinology and Diabetology Antwerp University Hospital, Belgium
Dr. Lawrence L. Gan, Director, Biogen Idec, Inc., USA
Dr. Liang Cheng, Professor, Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, USA
Dr. Liang Tang, Principal Research Scientist, Bayer HealthCare, USA
Dr. Lijun Sun, VP, Chemistry Synta Pharmaceuticals Corp, USA
Dr. Lingyun Chengk, Director of Ocular PharmacologykJacobs Retina Center/Shiley Eye Center, University of California, USA
Dr. Luigi Aurisicchio, Research Fellow, Group Leader, Merck & Co., Italy
Dr. Lutz Jermutus, Director of Research-Technology, Medimmune, UK
Dr. Mahboob Rahman, Senior Director, Centocor/Johnson & Johnson, USA
Dr. Makoto Ohori, Senior Researcher, Astellas Pharma Inc, Japan
Dr. Mandip Singh Sachdeva, Professor, Florida A&M University, USA
Dr. Manu V. Chakravarthy, Associate Director, Experimental Medicine, MERCK, USA
Dr. Manu V. Chakravarthy, Associate Director, Merck, USA
Dr. Manuel Buttini, Principal Scientist, Elan Pharmaceuticals, USA
Dr. Manuel Carrondo, Professor, Instituto De Biologia Experimentale Tecnologica, Portugal
Dr. Marco Bregni, Chair, Solid Tumor Working Party, Italy
Dr. Maria José Sá, Senior Neurologist, Hospital S Hospital S Joao, Portugal
Dr. Maricarmen Planas-Silva, Assistant Professor, Department of Pharmacology, Penn State College of Medicine, USA
Dr. Mark E. Anderson, Professor, University of Minnesota, Stanford University, USA
Dr. Mark S. Shearman, Executive Director, Neuroscience Drug Discovery, Merck Research Laboratories Boston, USA
Dr. Mark Truesdale, Senior Product Manager, Genetix Ltd, UK
Dr. Marketa J Zvelebil, Team Leader, Cancer Informatics, The Institute of Cancer Research, UK
Dr. Markus Tobler, Director, Zeptosens – a Division of Bayer (Schweiz) AG, Switzerland
Dr. Marlene L. Cohen, Lilly Research Fellow (retired), Adjunct Professor of Pharmacology, Eli Lilly and Company；Indiana University School of Medicine, USA
Dr. Matthias von Herrath, Professor, Institute for Allergy and Immunology, University of California, USA
Dr. Mauricio Rojas, Assistant Professor, Division of Pulmonary, Emory University, USA
Dr. Melvyn Little, CSO, Affimed Therapeutics AG, Germany
Dr. Michael B. Bolger, Chief Scientist and Director, Simulations Plus, Inc., USA
Dr. Michael J. Shapiro, Associate Professor, University of Maryland, USA
Dr. Michael J. Waring, Professor, the Wine Committee, Jesus College, England
Dr. Michal Dubovicky, Deputy Director, Institute of Experimental Pharmacology, Slovak
Dr. Ming Wang, Scientific Director, Amgen, Inc., USA
Dr. Mirko Diksic, Director, Department of Neurology and Neurosurgery, McGill University, Canada
Dr. Mitchell Ho, Head, Antibody Therapy Unit, National Cancer Institute, NIH, USA
Dr. Mohammad Mikati, Chairman and Professor, American University of Beirut, USA
Dr. Naitee Ting, Director, Biostatistics, Pfizer Inc., USA
Dr. Neil Press, Group Leader, Novartis Institutes for Biomedical Research, UK
Dr. Niek Dekker, Associate Director, AstraZeneca, Swedish
Dr. Nirmala Bhogal, Scientific Director, Fund for the Replacement of Animals in Medical Experiments (FRAME), UK
Dr. Ole Vesterqvist, Director,Biomarker Lab & Outsourcing, Clinical Translational Medicine, Wyeth Research, USA
Dr. Ole Vesterqvist, Senior Director, Biomarker Lab & Outsourcing, Clinical Translational Medicine, Wyeth Research, USA
Dr. Oleg Targoni, Director, Laboratory Cellular Technology Ltd., USA
Dr. Olof Larsson, Associated Director, Department of Molecular, Astrazeneca R&D Sodertolje, Sweden
Dr. Omar L. Francone, Research Fellow, Pfizer Global Research and Development, USA
Dr. Origène Nyanguile, Principal Scientist, Johnson & Johnson Pharmaceutical, USA
Dr. Oscar Joseph Trask, Head of Cellular Imaging Technologies Neurobiology, Duke University, USA
Dr. Pardeep K. Gupta, Associate Prof., University of the Sciences in Philadelphia, USA
Dr. Parminder Kaur, Managing Director, RegPak BioPharma Consulting, The Netherlands
Dr. Patricio F. Reyes, Director, Barrow Neurological Institute, USA
Dr. Paul M. Vanhoutte, Head of the Department of Pharmacology, University of Hong Kong, China
Dr. Paul Shapiro, Associate Dean for Research and Graduate Studies, University of Maryland School of Pharmacy, USA
Dr. Peter Hoffmann, VP New Technology Development, Genzyme Pharmaceuticals, USA
Dr. Ping Li, Senior Fellow, Novartis Pharma AG, USA
Dr. Piotr H. Karpinski, Principal Fellow, Novartis Pharmaceuticals Corporation, USA
Dr. Pirouz Daftarian, Director, Biological Modifiers/Hybridoma Core, University of Miami, USA
Dr. Prasad Tata, Manager-Pharmacokinetics, Mallinckrodt, Inc., USA
Dr. R.J.M.M. Thoolen, Toxicologic Pathologist, Global Pathology Support, The Netherlands
Dr. Radium Bhattacharya, Director, Gujarat AIDS Awareness and Prevention Unit, India
Dr. Ric M. Procyshyn, Associate Clinical Professor, University of British Columbia, Canada
Dr. Richard Beger, Branch Chief, Center for Metabolomics, National Center for Toxicological Research, USA
Dr. Richard Jeppsson, Public Affairs & Communication Director, sanofi aventis, USA
Dr. Richard White, Manager Toxicology and Pharmacology, OphthalmoPharma, Switzerland
Dr. Rob Jones, Director, Medicinal Chemistry, Arena Pharmaceuticals, USA
Dr. Robert Becker, V.P, Business Development, Vaxinnate, USA
Dr. Robert Guttendorf, Vice President of Pharmacology and Experimental Therapeutics, Sequoia Pharmaceuticals Inc., USA
Dr. Roland E. Dolle, Senior Director, Department of Chemistry, Adolor Corporation, USA
Dr. Ronald Rooke, Director, Immunopharmacology Dept, Transgene, France
Dr. Rosario LoBrutto, Project Leader, Novartis Pharmaceuticals Corporation, USA
Dr. Rouzbeh R. Taghizadeh, CSO, AuxoCell Laboratories, Inc., USA
Dr. Rubina Heptulla, Assistant Professor, Baylor College of Medicine, USA
Dr. Ruojing Yang, Senior research biologist, Merck & Co. Inc, USA
Dr. Ryuichi Morishita, Professor, Department of Clinical Gene Therapy, Osaka University, Japan
Dr. Sabrina C. Desbordes, Differentiation and Cancer Program, CRG-Centre de Regulació Genòmica, Spain
Dr. Saileta Prabhu, Scientist, Genentech, USA
Dr. Salomon Z. Langer, Vice President, Alpha-2 Pharmaceutica AB, Israel
Dr. Santosh R. D'Mello, Professor, Molecular and Cell Biology, University of Texas at Dallas, USA
Dr. Serge Guzy, CEO, XOMA (US) LLC, USA
Dr. Shaoxian Sun, Senior Principle Scientist, Pfizer Inc., USA
Dr. Shawn X. Yin, Senior Research Investigator, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, USA
Dr. Sheila Annie Peters, Associate Principal Scientist, Discovery DMPK & Bioanalytical Chemistry, AstraZeneca R&D, Sweden
Dr. Sherry Shen, analytical scientist, Boehringer Ingelheim Pharmaceutical Inc., USA
Dr. Siavoush Dastmalchi, Associate Professor, Tabriz University of Medical Sciences, Iran
Dr. Sid Topiol, Associate Director, Computational Chemistry Department, Lundbeck Research, USA
Dr. Sohaib Khan, Director, NCI Training Program in Cancer, UC College of Medicine, USA
Dr. Stefan Otto Mueller, Head, early and explanatory Toxicology, Merck KGaA, Germany
Dr. Stephan Schurer, Assistant Professor, Department of Pharmacology, University of Miami, USA
Dr. Steve Wilton, Head, Molecular Genetic Therapy, University of Western Australia, Australia
Dr. Steven Bodovitz, Principal, BioPerspectives, USA
Dr. Steven Hayes, Director, BellBrook Labs, LLC, USA
Dr. Stuart Madden, Senior Vice President of Product Development Consulting and Non Clinical Services, ICON PLC, USA
Dr. Sudhakar D. Garad, Group Head-Formulation Group, Novartis Institutes for Biomedical, USA
Dr. Susan Pond, CEO, Johnson & Johnson Research Pty Limited, Australia
Dr. Sushma Rathaur, Professor, Department of Biochemistry, Faculty of Science, Banaras Hindu University, India
Dr. Tao Wang, Principal Scientist, Bristol-Myers Squibb R&D, USA
Dr. Tim Hammonds, Head of Biochemistry and HTS, Cancer Research Technology, UK
Dr. Tomi Sawyer, Chief Scientific Officer, AILERON Therapeutics, USA
Dr. Toshikazu Hirao, Professor, Department of Applied Chemistry, Osaka University, Japan
Dr. Umesh R. Desai, Professor of Medicinal Chemistry and Interim Director, Virginia Commonwealth University, USA
Dr. Varghese John, Director, Alzheimer抯 Drug Discovery Network, USA
Dr. Vijay Kumar, Professor, University of Pennsylvania, USA
Dr. Vishal K. Gupta, Director, Pharmaceutical R&D, Covidien, USA
Dr. Viswanath Devanarayan, Director, Exploratory Statistics Global Pharmaceutical R&D, Abbott Laboratories, USA
Dr. Wenlin Huang, Senior Research Fellow, Institute of Microbiology,Chinese Academy of Sciences, China
Dr. Will Spooren, Project Leader, Hoffmann-La Roche, Switzerland
Dr. William N Washburn, Senior Research Fellow, Bristol-Myers Squibb Pharmaceutical Research Institute, USA
Dr. Wolfgang K.-D. Brill, Principal Research Scientist, Nerviano Medical Sciences s.r.I.Italy
Dr. Xian-Ming Zeng, Senior Director, Global Respiratory R&D, TEVA Pharmaceuticals, USA
Dr. Xiaoyu Liu, VP, R&D, Zhejiang Hisun Pharmaceutical Co., Ltd, China
Dr. Yin Liang, Head, Diabetes Section,Johnson & Johnson Pharmaceutical Research & Development, L.L.C, USA
Dr. Yogeshvar Kalia, Assistant Professor, University of Geneva, Switzerland
Dr. Yong-Jin Wu, senior scientist, Bristol-Myers Squibb, USA
Dr. Yoshiya Oda, Director, Eisai Co., Ltd., Japan
Dr. Yunsheng Hsieh, Principal Scientist, Schering-Plough Research, USA
Dr. Yvon C. Chagnon, Associate Professor, Laval University, Canada
Dr. Zaher A. Radi, Associate Research Fellow-Toxicologic Pathologist, Pfizer Global Research & Development, USA
Dr. Zhiyang Zhao, Director of Preclinical, Amgen, USA
|
About IDDST
